Loading clinical trials...
Loading clinical trials...
Skin Microcirculation Evaluation With Nailfold Capillaroscopy in Cushing's Syndrome Patients
This cross-sectional, single-center study will assess the microvascular function using a nailfold video-capillaroscopy in patients with endogenous Cushing syndrome.
Endogenous Cushing's syndrome (CS) is associated with increased macrovascular diseases and impaired endothelial function. There is no clear data about the effects of hypercortisolism on microcirculation. The primary aim of this study is to evaluate the peripheric microvascular area in patients with Cushing's syndrome. The association of microvascular changes with present comorbidities (diabetes, hypertension, etc.) and disease activation will be evaluated. Method: Cushing syndrome patients admitted to our clinic will be included in this study for the next six months after given informed consent. The following clinical laboratory parameters will be evaluated as cross-sectionally. Previous medical history, available laboratory parameters (fasting plasma glucose, HbA1c, total cholesterol, triglyceride, HDL, LDL, creatine, AST, ALT, complete blood count, ACTH, dexamethasone suppression tests (1 mg- 2mg), urine free cortisol, FSH, LH, total testosterone, estradiol, IGF-1, TSH, free T3, free T4, prolactin), radiologic images (Cranial MRI and Adrenal MRI) will be recorded from medical charts. Nailfold microcirculation will be evaluated with video-capillaroscopy: it is a non-invasive atraumatic assessment of the morphology and some functional aspects of cutaneous capillaries.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
Marmara University Medical School Section of Endocrinology and Metabolism
Istanbul, Turkey (Türkiye)
Start Date
June 15, 2020
Primary Completion Date
December 31, 2020
Completion Date
January 15, 2021
Last Updated
June 16, 2020
200
ESTIMATED participants
Lead Sponsor
Marmara University
NCT06573723
NCT06246357
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions